NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 115 filers reported holding NURIX THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $350,438 | -31.3% | 44,585 | -12.7% | 0.00% | 0.0% |
| Q2 2023 | $510,099 | +18.9% | 51,061 | +5.7% | 0.00% | 0.0% |
| Q1 2023 | $429,037 | -20.5% | 48,315 | -1.7% | 0.00% | 0.0% |
| Q4 2022 | $539,788 | -12.5% | 49,161 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $617,000 | +3.0% | 47,323 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $599,000 | +40.6% | 47,246 | +55.6% | 0.00% | 0.0% |
| Q1 2022 | $426,000 | -56.4% | 30,372 | -10.1% | 0.00% | 0.0% |
| Q4 2021 | $978,000 | -2.0% | 33,799 | +1.5% | 0.00% | 0.0% |
| Q3 2021 | $998,000 | -12.9% | 33,312 | -22.9% | 0.00% | 0.0% |
| Q2 2021 | $1,146,000 | +2.0% | 43,188 | +19.6% | 0.00% | 0.0% |
| Q1 2021 | $1,123,000 | +94.0% | 36,111 | +104.9% | 0.00% | 0.0% |
| Q4 2020 | $579,000 | -1.4% | 17,620 | +4.8% | 0.00% | 0.0% |
| Q3 2020 | $587,000 | – | 16,805 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXCHANGE TRADED CONCEPTS, LLC | 15,823 | $163,293 | 0.00% |